| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0140-6736(01)06002-0 |
| P698 | PubMed publication ID | 11564491 |
| P50 | author | Sadayoshi Itō | Q30932255 |
| P2093 | author name string | K Takahashi | |
| Y Kimura | |||
| H Sasano | |||
| F Satoh | |||
| K Totsune | |||
| M Sone | |||
| O Murakami | |||
| Z Arihara | |||
| P2860 | cites work | Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14 | Q22010575 |
| Orphan-receptor ligand human urotensin II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1 | Q24674639 | ||
| Human urotensin-II is an endothelium-dependent vasodilator in rat small arteries | Q41859635 | ||
| Detection of immunoreactive endothelin in plasma of hemodialysis patients | Q44501519 | ||
| P433 | issue | 9284 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 810-811 | |
| P577 | publication date | 2001-09-01 | |
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Role of urotensin II in patients on dialysis | |
| P478 | volume | 358 |
| Q47431351 | A Comparison of Cerebrospinal Fluid and Plasma Urotensin II Concentrations in Normotensive and Hypertensive Patients Undergoing Urological Surgery During Spinal Anesthesia: A Pilot Study |
| Q37737587 | A rat brain atlas of urotensin-II receptor expression and a review of central urotensin-II effects |
| Q36224889 | An investigation into the expression and mechanism of action of urotensin II in chronic pressure-overloaded rat hearts |
| Q42667921 | Behavioral effects of urotensin-II centrally administered in mice |
| Q76383741 | Cardiovascular actions of human urotensin II--considerations for hypertension |
| Q42215972 | Deletion of the UT receptor gene results in the selective loss of urotensin-II contractile activity in aortae isolated from UT receptor knockout mice |
| Q48626800 | Does cigarette smoking increase plasma urotensin II concentrations? |
| Q35033297 | Emerging roles for orphan G-protein-coupled receptors in the cardiovascular system |
| Q40659791 | Expression of urotensin II and its receptor in adrenal tumors and stimulation of proliferation of cultured tumor cells by urotensin II. |
| Q28208515 | Identification of urotensin II-related peptide as the urotensin II-immunoreactive molecule in the rat brain |
| Q35098581 | In vitro and in vivo pharmacological characterization of the novel UT receptor ligand [Pen5,DTrp7,Dab8]urotensin II(4-11) (UFP-803) |
| Q78554340 | Increased urotensin II plasma levels in patients with cirrhosis and portal hypertension |
| Q24672927 | Is urotensin-II the new endothelin? |
| Q48675996 | Localization of the urotensin II receptor in the rat central nervous system |
| Q42284302 | No effect on central or peripheral blood pressure of systemic urotensin II infusion in humans. |
| Q40430686 | Nonpeptidic urotensin-II receptor antagonists I: in vitro pharmacological characterization of SB-706375. |
| Q36328664 | Plasma Urotensin II levels in children and adolescents with chronic kidney disease: a single-centre study |
| Q28216724 | Plasma levels and cardiovascular gene expression of urotensin-II in human heart failure |
| Q74811631 | Plasma urotensin II in heart failure |
| Q35128456 | Potential Clinical Implications of the Urotensin II Receptor Antagonists |
| Q28249171 | Renal and vascular actions of urotensin II |
| Q35025464 | Renal impairment, hypertension and plasma urotensin II. |
| Q36902874 | Role of urotensin II and its receptor in health and disease |
| Q48372089 | Signaling switch of the urotensin II vasosactive peptide GPCR: prototypic chemotaxic mechanism in glioma. |
| Q33599835 | The G Protein-Coupled Receptor UT of the Neuropeptide Urotensin II Displays Structural and Functional Chemokine Features |
| Q24675590 | The role of urotensin II in cardiovascular and renal physiology and diseases |
| Q36760529 | Therapeutic potential of blockade of the urotensin II system in systemic hypertension |
| Q42578695 | Urotensin II Exerts Pressor Effects By Stimulating Renin And Aldosterone Synthase Gene Expression. |
| Q28576132 | Urotensin II and renal function in the rat |
| Q37344439 | Urotensin II in cardiovascular regulation |
| Q81793693 | Urotensin II in patients with chronic heart failure |
| Q64237884 | Urotensin II in the development and progression of chronic kidney disease following ⅚ nephrectomy in the rat |
| Q58949856 | Urotensin II is an inverse predictor of incident cardiovascular events in end-stage renal disease |
| Q35152923 | Urotensin II promotes atherosclerosis in cholesterol-fed rabbits |
| Q40470611 | Urotensin II stimulates plasma extravasation in mice via UT receptor activation. |
| Q37148984 | Urotensin II: lessons from comparative studies for general endocrinology. |
| Q83315856 | Urotensin-II in systemic sclerosis: a new peptide in pathogenesis |
| Q36357772 | Urotensin-II induces ear flushing in rats |
| Q45189333 | Urotensin-II levels in children with minimal change nephrotic syndrome |
| Q35082405 | Urotensin-II system in genetic control of blood pressure and renal function |
| Q42418210 | Urotensin-II: More Than a Mediator for Kidney |
| Q33705948 | Urotensin‐II receptor antagonism does not improve renal haemodynamics or function in rats with endotoxin‐induced acute kidney injury |
Search more.